Drugs Made In America Acquisition II Corp. (DMIIU) Total Current Liabilities (2024 - 2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Total Current Liabilities of $300864.0 for Q4 2025, up 18.09% year-over-year from $254783.0 in Q4 2024, and down 55.58% quarter-over-quarter from $677345.0 in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Total Current Liabilities (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Total Current Liabilities for 2 consecutive years, with $300864.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities rose 18.09% year-over-year to $300864.0; the TTM figure through Dec 2025 stood at $300864.0 (up 18.09% YoY), while the FY2025 annual figure was $300864.0, up 18.09% from the prior year.
- Total Current Liabilities fell to $300864.0 in Q4 2025 per DMIIU's latest filing, from $677345.0 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $677345.0 in Q3 2025 and bottomed at $254783.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 300,864.00 |
| Sep 30, 2025 | 677,345.00 |
| Dec 31, 2024 | 254,783.00 |